| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.038 | 0.5 |